e-learning
resources
Virtual 2021
07.09.2021
From pathophysiology to different diagnostic modalities in sleep disordered breathing
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Sleep apnea syndrome and atherosclerosis: VE-Cadherin as a new antiatherogenic target?
O. Harki (Grenoble, France), S. Sophie Bouyon (Grenoble, France), E. Emeline Lemarie (Grenoble, France), A. Demory (Grenoble, France), I. Vilgrain (Grenoble, France), J. Pépin (Grenoble, France), G. Faury (Grenoble, France), A. Briançon-Marjollet (Grenoble, France)
Source:
Virtual Congress 2021 – From pathophysiology to different diagnostic modalities in sleep disordered breathing
Session:
From pathophysiology to different diagnostic modalities in sleep disordered breathing
Session type:
Oral Presentation
Number:
3020
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Harki (Grenoble, France), S. Sophie Bouyon (Grenoble, France), E. Emeline Lemarie (Grenoble, France), A. Demory (Grenoble, France), I. Vilgrain (Grenoble, France), J. Pépin (Grenoble, France), G. Faury (Grenoble, France), A. Briançon-Marjollet (Grenoble, France). Late Breaking Abstract - Sleep apnea syndrome and atherosclerosis: VE-Cadherin as a new antiatherogenic target?. 3020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Late Breaking Abstract - Differential effect of intermittent hypoxia and sleep fragmentation in the progression of Alzheimer Disease in a mouse model of obstructive sleep apnea
Source: International Congress 2018 – Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia
Year: 2018
Late Breaking Abstract - Plasma metabolomics identifies obstructive sleep apnoea hypopnoea syndrome (OSAHS)
Source: Virtual Congress 2021 – Sleep across the lifespan in the new era of COVID - 19
Year: 2021
Late Breaking Abstract: Exposure to passive smoking as a risk factor for developing obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2010 - Passive smoking
Year: 2010
Late Breaking Abstract - Obesity hypoventilation syndrome treated with non-invasive ventilation: can we switch to CPAP?
Source: International Congress 2017 – New insights in chronic respiratory failure
Year: 2017
Stroke and sleep apnoea: a deadly association?
Source: International Congress 2014 – ME08 Stroke and sleep apnoea: a deadly association?
Year: 2014
Obstructive sleep apnoea in acute coronary syndrome: the invisible threat?
Source: Eur Respir J , 49 (3) 1602539; DOI: 10.1183/13993003.02539-2016
Year: 2017
A novel connection: Obstructive sleep apnoea and diabetic neuropathy
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
Late Breaking Abstract - Effectiveness of multimodal remote patient monitoring at CPAP initiation in Obstructive Sleep Apnea (OSA) with high cardiovascular risk: A randomized trial
Source: International Congress 2017 – Risk factors: symptomatology and diagnostic approaches for obstructive sleep apnoea
Year: 2017
Obstructive sleep apnoea in mucopolysaccharidosis I: The role of phenotype and treatment on clinical outcome
Source: International Congress 2014 – Sleep disordered breathing: from children to the elderly
Year: 2014
Late Breaking Abstract - Obstructive Sleep Apnoea in an Irish Bariatric Population
Source: International Congress 2018 – Obesity: comorbidities
Year: 2018
Late Breaking Abstract - Inflammation and metabolic syndrome exacerbate pulmonary hypertension associated with left heart disease.
Source: International Congress 2019 – Pulmonary hypertension: new therapeutic pathways and modalities
Year: 2019
5-lipoxygenase pathway: one of the mediators of early atherosclerosis in obstructive sleep apnea syndrome?
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007
Subclinical atherosclerosis in obstructive sleep apnea (OSA): The EPIOSA study
Source: International Congress 2015 – Paediatric and adult sleep-disordered breathing: from inflammation to treatment and telemedicine
Year: 2015
Assessment of impaired in vitro endothelial repair function in obstructive sleep apnea patients and impact of associated metabolic syndrome
Source: Annual Congress 2013 –Of mice and men: sleep disordered breathing
Year: 2013
Gender differences in obstructive sleep apnoea: Getting old or fat, what matters?
Source: International Congress 2016 – Epidemiological aspects of obstructive sleep apnoea
Year: 2016
Late Breaking Abstract - Long-term noninvasive ventilation in obesity hypoventilation syndrome without severe obstructive sleep apnoea
Source: Virtual Congress 2020 – ALERT: Ventilation and rehabilitation
Year: 2020
Obstructive sleep apnea syndrome and cardiometabolic disorders – Is there an association?
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies
Year: 2015
Is there a relationship between OSAS severity and Nesfatin-1?
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015
Obstructive sleep apnea syndrome: How are we in Portugal?
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies
Year: 2015
Late Breaking Abstract - Pilot study for a new diagnostic supply process for patients with sleep related breathing disorders
Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept